The combined role of NT-proBNP and LV-GLS in the detection of early subtle chemotherapy-induced cardiotoxicity in breast cancer female patients

Abstract

Background Chemotherapeutic agents have many side effects; among them is cardiotoxicity. Ejection fraction fails to detect the subtle alterations of left ventricular (LV) function; that is why there is a need for a more sensitive tool. The aim is to detect subclinical LV systolic dysfunction after chemotherapeutic treatment, using NT-BNP plasma level as well as speckle tracking echo-global longitudinal strain (STE-GLS). Seventy-four asymptomatic, non-metastasizing breast cancer female patients without risk factors were included. They were assessed before and 6 weeks after taking their first chemotherapeutic session. Assessment included clinical characteristics, conventional two-dimensional (2D) and three-dimensional (3D) echocardiography, and 2D STE-GLS. Blood samples for NT-BNP plasma level were collected on both visits and were later analyzed using a Sandwich ELISA technique. Results The median NT-proBNP almost doubled after 6 weeks of chemotherapy (73.50 vs 34.4 pg/L, p value <0.001). Only two patients showed significant reduction of LVEF >10% to less <55%. One patient died before her scheduled follow-up visit, and the cause of death is unknown. Fifty patients showed elevated follow-up levels of the NT-BNP. As compared to the baseline visit, 12 patients had a high relative reduction of the LV-GLS (>15%) and all of them had a relatively higher NT-proBNP. A 2.2 relative elevation of the NT-proBNP was able to define a relative reduction of LV-GLS >15% by a 100% sensitivity and 81.8% specificity. Conclusion The relative reduction of LV-GLS and the relative elevation of NT-proBNP were successful in defining subclinical, subtle chemotherapy-induced cardiotoxicity after 6 weeks of the first chemotherapeutic agent administration.

Doxorubicin-induced acute cardiotoxicity is associated with increased oxidative stress, autophagy, and inflammation in a murine model

“…DOX-induced molecular alterations in the cardiac muscle could still occur in clinically asymptomatic patients, as the functional impact can be too subtle to detect (Sulaiman et al 2021 ), leading to a progressive weakening of the heart muscle which may appear much later in life. Strategies for the prevention of DOX-induced cardiotoxicity are already being used in oncological patients.…”

Risk Factors for Anthracycline-Induced Cardiotoxicity

“…In recent years, due to advances in cancer treatment and early detection strategies, the mortality rates of cancer have significantly declined ( 1 ). Studies have shown that in the next 10 years, long-term cancer survivors are expected to increase by about 30% ( 2 ).…”

Precision Cardio-oncology: Update on Omics-Based Diagnostic Methods

“…In a clinical observational cohort study examining NT-proBNP and echocardiography in 74 patients undergoing chemotherapy for breast cancer, there was a strong association between increased NT-proBNP levels and decreased LV-GLS in identifying cardiotoxicity. The results of the study showed good sensitivity and specificity [103]. The relative reduction of LV-GLS, the relative elevation of NT-proBNP 6 weeks after the first chemotherapy dose…”